These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18834374)

  • 1. Treatment of panic disorder with bupropion in a patient with Parkinson's disease.
    Gebhardt S; Röttgers H; Bäcker A; Schu U; Krieg JC
    J Clin Pharm Ther; 2008 Oct; 33(5):575-7. PubMed ID: 18834374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment of depression in a Parkinson disease patient with bupropion].
    Leentjens AF; Verhey FR; Vreeling FW
    Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2157-9. PubMed ID: 11086491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion as the treatment of choice in depression associated with Parkinson's disease and it's various treatments.
    Raskin S; Durst R
    Med Hypotheses; 2010 Dec; 75(6):544-6. PubMed ID: 20708340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion in the management of apathy.
    Corcoran C; Wong ML; O'Keane V
    J Psychopharmacol; 2004 Mar; 18(1):133-5. PubMed ID: 15107198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion sustained release for panic disorder.
    Simon NM; Emmanuel N; Ballenger J; Worthington JJ; Kinrys G; Korbly NB; Farach FJ; Pollack MH
    Psychopharmacol Bull; 2003; 37(4):66-72. PubMed ID: 15131517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of buspirone and bupropion in the treatment of depression.
    Fava M
    Psychother Psychosom; 2007; 76(5):311-2. PubMed ID: 17700052
    [No Abstract]   [Full Text] [Related]  

  • 7. Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease.
    Benincasa D; Pellicano C; Fanciulli A; Pontieri FE
    Mov Disord; 2011 Feb; 26(2):355-7. PubMed ID: 21412840
    [No Abstract]   [Full Text] [Related]  

  • 8. Bupropion and panic disorder: case report and review of the literature.
    Serafini G; Pompili M; Fusar-Poli P; Porfiri G; Giordano G; Ferracuti S; Girardi P; Tatarelli R
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E47-50. PubMed ID: 21677228
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychopharmacology of smoking cessation in patients with mental illness.
    Selby P
    J Psychiatry Neurosci; 2006 Sep; 31(5):360. PubMed ID: 16951737
    [No Abstract]   [Full Text] [Related]  

  • 10. Depression and panic disorder after heart transplantation--treatment with sertraline.
    Hesslinger B; Van de Loo A; Klecha D; Härter M; Schmidt-Schweda S
    Pharmacopsychiatry; 2002 Jan; 35(1):31-2. PubMed ID: 11819158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual hallucinations from the addition of riluzole to memantine and bupropion.
    Pittenger C; Naungayan C; Kendell SF; Coric V; Malison R; Krystal JH; Sanacora GS
    J Clin Psychopharmacol; 2006 Apr; 26(2):218-20. PubMed ID: 16633160
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease: a preliminary study of yohimbine challenge in patients with anxiety.
    Richard IH; Szegethy E; Lichter D; Schiffer RB; Kurlan R
    Clin Neuropharmacol; 1999; 22(3):172-5. PubMed ID: 10367182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restless legs syndrome induced by citalopram: a psychiatric emergency?
    Perroud N; Lazignac C; Baleydier B; Cicotti A; Maris S; Damsa C
    Gen Hosp Psychiatry; 2007; 29(1):72-4. PubMed ID: 17189751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
    Pae CU; Lim HK; Han C; Patkar AA; Steffens DC; Masand PS; Lee C
    Expert Rev Neurother; 2007 Oct; 7(10):1251-63. PubMed ID: 17939764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of electroconvulsive therapy in treatment of retinitis pigmentosa comorbid with major depressive disorder and panic disorder.
    Chang TG; Wang CH; Chiu NY; Hsu WY
    J ECT; 2011 Dec; 27(4):e57-8. PubMed ID: 22124224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine related effects of brain structure on a patient of major depressive disorder with panic disorder.
    Lai CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):240-1. PubMed ID: 19833160
    [No Abstract]   [Full Text] [Related]  

  • 17. Bupropion-induced sleepwalking.
    Oulis P; Kokras N; Papadimitriou GN; Masdrakis VG
    J Clin Psychopharmacol; 2010 Feb; 30(1):83-4. PubMed ID: 20075658
    [No Abstract]   [Full Text] [Related]  

  • 18. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.
    Schönfeldt-Lecuona C; Connemann BJ; Wolf RC; Braun M; Freudenmann RW
    Pharmacopsychiatry; 2006 Jul; 39(4):152-4. PubMed ID: 16871471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion for the treatment of neuropathic pain.
    Shah TH; Moradimehr A
    Am J Hosp Palliat Care; 2010 Aug; 27(5):333-6. PubMed ID: 20185402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of bupropion in the treatment of pemoline dependence.
    Martín Morgado B; Vaz Leal FJ; Bolívar Perálvarez M; Guisado Macías JA
    Actas Esp Psiquiatr; 2007; 35(4):277-8. PubMed ID: 17592792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.